Evidence map›Paper›PMID 28503667›Full record

ArticleWellcome open research2017

Neopeptide Analyser: A software tool for neopeptide discovery in proteomics data.

Mandy Peffers, Andrew R Jones, Antony McCabe, James Anderson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Wellcome open research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Journal of proteome research · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mandy PeffersInstitute of Ageing and Chronic Disease, University of Liverpool, Liverpool, L7 9TX, UK.ORCID 0000-0001-6979-0440
Andrew R JonesInstitute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK.
Antony McCabeInstitute of Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK.
James AndersonInstitute of Ageing and Chronic Disease, University of Liverpool, Liverpool, L7 9TX, UK.
University of Liverpool · GB

Funding

Medical Research Council MR/K006312/1Wellcome Trust 107471
6 · The paper itself

Abstract

Experiments involving mass spectrometry (MS)-based proteomics are widely used for analyses of connective tissues. Common examples include the use of relative quantification to identify differentially expressed peptides and proteins in cartilage and tendon. We are working on characterising so-called 'neopeptides', i.e. peptides formed due to native cleavage of proteins, for example under pathological conditions. Unlike peptides typically quantified in MS workflows due to the

Indexed as

biomarkerextra-cellular matrixmass spectrometryneopeptideProgenesis QIPproteomicssemi-tryptic

Identifiers

PMID28503667
PMCPMC5428739
OpenAlexW2604943019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.